This program will have a major impact in the treatment of cardiovascular disease (CVD), the leading cause of death in men and women globally. Premenopausal women are less susceptible to heart disease than men, and this protection is lost after menopause. Emerging data suggest that the interplay between nitric oxide (NO) and reactive oxygen species (ROS), the nitroso-redox balance, plays a critical role in this sex-related cardioprotection. Elucidating the mechanisms underlying these gender differences is critical for development of effective therapies. S-nitrosylation (S-NO) of cysteine thiols is a major signaling pathway through which NO exerts its broad regulatory actions. It is increasingly appreciated that the underlying signaling fate of NO ultimately depends upon an intracellular state of nitroso-redox balance; such that excessive production of ROS can disrupt physiological S-NO and that CVD may reflect dysregulated protein S- NO. We have shown that the nitroso/redox balance is an important regulator of CV health and disease. Female mice have 65% more S-nitrosylated proteins in the heart6 and physiologically regulate this elevated level of S- NO with increased activity of S-nitrosoglutathione (GSNO) reductase (GSNOR), an enzyme that promotes protein denitrosylation. We previously showed that male mice lacking S-nitrosoglutathione (GSNO) reductase, an enzyme that governs S-NO levels by promoting protein denitrosylation (GSNOR??? mice) exhibit improved survival after myocardial infarction (MI). Furthermore, pregnant GSNOR?/? mice exhibit all of the clinical features of a major complication in pregnancy, preeclampsia (PE), including maternal hypertension, proteinuria and abnormal CV adaptation. Poor outcome in the GSNOR?/? females may be due to oxidative stress, as our preliminary data shows that cardiomyocytes (CMs) from GSNOR?/? females generate more ROS as compared to CMs from control females and GSNOR?/? males. Therefore, the state of increased S-NO can lead to an adverse milieu if accompanied by oxidative stress and we have uncovered a sex-associated relationship between cardiac pathology and intra-cellular nitroso-redox imbalance, which is dependent on NO and ROS production and S-NO formation and denitrosylation. Our central hypothesis is that the absence of GSNOR produces a sex-specific, antioxidant milieu in the setting of normal ROS levels (i.e., males) but one of nitrosative/oxidative stress when ROS is elevated (i.e., females). Our proposal aims to identify the fundamental mechanisms underlying this dichotomy.
The specific aims are to test the hypotheses that 1) differences in nitroso-redox protein signaling determine sex-specific responses to CV stress; 2) nitroso-redox imbalance in cadiomyocytes during pregnancy underlies pregnancy-related CVD; and 3) GSNOR produces sex-specific changes in the S-nitrosylation of proteins that alter CV function. Together these aims will provide novel insights into nitroso-redox regulation of cardiac function in response to physiologic and pathophysiologic stressors and have significant implications for the treatment of CVD in men and women.

Public Health Relevance

Myocardial infarction occurs when blood supply to the heart is inadequate and this represents a leading cause of death for men and women worldwide. Women experience their first myocardial infarction about 10 years later than men, but are more likely to die from myocardial infarction than men. In this proposal, we will explore gender-based mechanisms through which the heart protects itself against injury. Our findings will have implications for developing new sex-specific therapeutic strategies for myocardial infarction and other related cardiovascular diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL137355-04
Application #
9857640
Study Section
Cardiac Contractility, Hypertrophy, and Failure Study Section (CCHF)
Program Officer
Schwartz, Lisa
Project Start
2017-03-17
Project End
2021-02-28
Budget Start
2020-03-01
Budget End
2021-02-28
Support Year
4
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Miami School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
052780918
City
Coral Gables
State
FL
Country
United States
Zip Code
33146
Premer, Courtney; Schulman, Ivonne Hernandez (2018) Predictive Value of Circulating Progenitor Cells in Acute Coronary Syndrome: Implications for Treatment. Circ Res 122:1491-1493
Premer, Courtney; Schulman, Ivonne H (2018) Have We Been Measuring the Wrong Form of Vitamin D? Circ Res 123:934-935
Bagno, Luiza; Hatzistergos, Konstantinos E; Balkan, Wayne et al. (2018) Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges. Mol Ther 26:1610-1623
Schulman, Ivonne Hernandez; Khan, Aisha; Hare, Joshua M (2018) Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine. Circ Res 123:1030-1032
Schulman, Ivonne Hernandez; Balkan, Wayne; Hare, Joshua M (2018) Mesenchymal Stem Cell Therapy for Aging Frailty. Front Nutr 5:108
Bolli, Roberto; Hare, Joshua (2018) Introduction to a Compendium on Regenerative Cardiology. Circ Res 123:129-131
Arora, Himanshu; Panara, Kush; Kuchakulla, Manish et al. (2018) Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth. Proc Natl Acad Sci U S A 115:11298-11303
Bellio, Michael A; Pinto, Mariana T; Florea, Victoria et al. (2017) Hypoxic Stress Decreases c-Myc Protein Stability in Cardiac Progenitor Cells Inducing Quiescence and Compromising Their Proliferative and Vasculogenic Potential. Sci Rep 7:9702
Gesmundo, Iacopo; Miragoli, Michele; Carullo, Pierluigi et al. (2017) Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure. Proc Natl Acad Sci U S A 114:12033-12038